Charles-André Brouwers

Charles-André Brouwers has extensive work experience in various companies and roles. Charles-André is currently the Founder and Managing Partner at Galileo Life Sciences and also holds the position of Managing Director, Investment Banking at Galileo Global Securities LLC. In addition, they serve as the President of BelCham.

Throughout their career, Charles-André has also held roles such as Independent Director at N-SIDE, Independent Director & Chairman at OncoDNA, and Independent Director at Elysia-raytest. Prior to their current positions, they worked at Boston Consulting Group (BCG) as a Senior Partner and Managing Director for over two decades. Before that, they were Vice President - Head of Life Sciences Division at Cap Gemini and Bossard Gemini Consulting.

Charles-André's early career started as a Project Manager at Gemini Consulting. Overall, they have a strong background in management and leadership, particularly in the life sciences sector.

Charles-André Brouwers obtained a degree in Electronic & Computer Engineering from the University of Liège, where they studied from 1981 to 1986. Charles-André then pursued further education, earning an MSIA/MBA in Business Administration from Carnegie Mellon University's Tepper School of Business, attending from 1988 to 1990. Additionally, Charles-André Brouwers has obtained certifications in the field of finance, namely the S63 - Uniform Securities Agent State Law Examination, S79TO - Investment Banking Registered Representative Examination, and SIE - Securities Industry Essentials Examination, from FINRA. The specific years when these certifications were obtained are not provided.